Biopharmaceutical News and Research

RSS

New therapeutic target for rheumatoid arthritis and type 2 diabetes

There is a growing body of knowledge that points that type 2 diabetes, a chronic disease where the blood sugar increases, is an inflammatory disease. The levels of certain inflammatory chemicals, dubbed as cytokines, are often higher in people with type 2 diabetes, than healthy people.

16 Sep 2019

Promising new drug being developed for polycystic kidney disease

Researchers have developed a potential new drug for the treatment of Polycystic kidney disease (PKD) – a deadly genetic condition affecting the kidneys that leads to formation of swellings or cysts within the kidney that cause it to fail.

12 Sep 2019

Engaging community pharmacists to improve access to care for people with epilepsy

The University of Washington's School of Pharmacy announced on Thursday, Sept. 12, a collaboration with global biopharmaceutical company UCB to improve access to care for people living with epilepsy.

12 Sep 2019

BIA Separations launches Cornerstone AAV Process Development Service to improve gene therapy production

BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of CORNERSTONE AAV Process Development Service, a program of integrated process development services and novel technology designed to improve the robustness and yield of AAV-based gene therapy production, while improving the safety of therapeutic products.

12 Sep 2019

VUMC partners with Batavia to move promising Zika antibody therapy closer to the clinic

Researchers at Vanderbilt University Medical Center are partnering with the Dutch biopharmaceutical firm Batavia Biosciences and Nashville-based IDBiologics to bring to the clinic a highly potent Zika virus neutralizing antibody they isolated three years ago.

6 Sep 2019

$15 million grant funds new effort to develop universal vaccine for strep throat infections

CARB-X, an international non-profit partnership of private, academic and government institutions, has awarded SutroVax, Inc., a Northern California-based biopharmaceutical company, with an award of up to $15 million to develop a universal vaccine for Group A Streptococcus, the bacteria that causes pharyngitis or strep throat.

4 Sep 2019

New NC State-led project to focus on the future of biomanufacturing

A new 5-year project led by North Carolina State University will sponsor an international collaborative research and training program in biomanufacturing science and technology.

29 Aug 2019

Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with Partner Therapeutics, Inc., an integrated biopharmaceutical company.

From Tanner Pharma Group 29 Aug 2019

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Tanner Pharma Group, a global provider of integrated specialty access solutions, has announced the signing of a distribution agreement with MannKind Corporation, a biopharmaceutical company focused on inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension.

From Tanner Pharma Group 29 Aug 2019

Investigational drug reduces stuttering symptoms in open-label pilot study

A team led by a psychiatrist at the University of California, Riverside, has tested the orally administered investigational medication ecopipam on adults who stutter in an open-label, uncontrolled clinical trial and found that it reduced their stuttering symptoms from the start of therapy after eight weeks of dosing.

28 Aug 2019

Enable Injections enters into a development agreement with Genentech

Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuseTM, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.

21 Aug 2019

MSD collaborates with Francis Crick to find causes of motor neurone disease

Scientists at global biopharmaceutical company MSD and the Francis Crick Institute have started a unique new collaboration to understand the causes of Motor Neurone Disease and identify potential targets for future treatments, co-funded by MSD and the UK Medical Research Council.

21 Aug 2019

Albumedix ground-breaking ceremony

May 8th marked a big day in Albumedix’s history. Holding a traditional ground-breaking ceremony; our workforce, builders and contractors all gathered to watch Peter Rosholm (Chief Executive Officer) and Stuart Woodward (Chief Manufacturing Officer) take the first official step towards the company’s expansion.

From Albumedix Ltd. 20 Aug 2019

Mallinckrodt publishes results of StrataGraft regenerative tissue Phase 1b study

Mallinckrodt plc, a leading global biopharmaceutical company, today announced publication of results of its Phase 1b clinical trial of StrataGraft, an investigational regenerative tissue, in Burns, the journal of the International Society for Burn Injuries.

16 Aug 2019

Sartorius Stedim Biotech announces launch of new services for mammalian cell bank manufacturing

Sartorius Stedim Biotech (SSB), a leading partner of the biopharmaceutical industry, today announced the launch of new services for mammalian cell bank manufacture under GMP conditions.

From Sartorius 13 Aug 2019

Promising antibody therapy reduces tumor growth, increases survival in mice with pancreatic cancer

Scientists have found a way to target and knock out a single protein that they have discovered is widely involved in pancreatic cancer cell growth, survival and invasion.

31 Jul 2019

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

The Alzheimer's Association has awarded Longeveron LLC, a Miami-based biopharmaceutical company that develops cellular therapies for aging-related diseases, a $3 million grant to be applied to the company's mesenchymal stem cell Alzheimer's research.

23 Jul 2019

Four young scientists receives Damon Runyon-Sohn Pediatric Cancer Fellowship Award

The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $1 million to help address a critical shortage of funding for pediatric cancer research.

17 Jul 2019

Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

Quanterix marks major milestones as it continues to expand its footprint in neurology and lead the digital biomarker revolution across healthcare.

From Quanterix 11 Jul 2019

New alliance will focus on the structural visualization of novel druggable sites

PhoreMost has entered into an alliance with CCBT in India for the structural visualization of novel druggable sites across multiple targets.

From PhoreMost 8 Jul 2019

Biopharmaceutical News and Research

New therapeutic target for rheumatoid arthritis and type 2 diabetes

Promising new drug being developed for polycystic kidney disease

Engaging community pharmacists to improve access to care for people with epilepsy

BIA Separations launches Cornerstone AAV Process Development Service to improve gene therapy production

VUMC partners with Batavia to move promising Zika antibody therapy closer to the clinic

$15 million grant funds new effort to develop universal vaccine for strep throat infections

New NC State-led project to focus on the future of biomanufacturing

Tanner Pharma Group signs a distribution agreement for partner therapeutics’ product

Tanner Pharma Group signs distribution agreement with MannKind Corporation

Investigational drug reduces stuttering symptoms in open-label pilot study

Enable Injections enters into a development agreement with Genentech

MSD collaborates with Francis Crick to find causes of motor neurone disease

Albumedix ground-breaking ceremony

Mallinckrodt publishes results of StrataGraft regenerative tissue Phase 1b study

Sartorius Stedim Biotech announces launch of new services for mammalian cell bank manufacturing

Promising antibody therapy reduces tumor growth, increases survival in mice with pancreatic cancer

Alzheimer's Association awards $3 million grant to support Longeveron's innovative clinical trial

Four young scientists receives Damon Runyon-Sohn Pediatric Cancer Fellowship Award

Quanterix to convene leading industry researchers at Alzheimer’s Association International Conference 2019 following closing of UmanDiagnostics acquisition

New alliance will focus on the structural visualization of novel druggable sites

Pittcon Highlights: Pharmaceutical & Biologic eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News